---
$id: https://graph.org.ai/products/commodity/51341904
$type: Product
source: UNSPSC
code: "51341904"
title: "Maraviroc"
class: "51341900"
classTitle: "Antiviral amidines and amines and benzoxazines and cyclohexanes"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Maraviroc

**UNSPSC Code**: 51341904
**Class**: [Antiviral amidines and amines and benzoxazines and cyclohexanes](Antiviral amidines and amines and benzoxazines and cyclohexanes.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a chemokine receptor antagonist and anti-hiv agent with the molecular formula C29H41F2N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MD6P741W8A, chemically known as uk-427,857 but generally known as maraviroc, which bears US NIH Compound Identifier 3002977. European Medicines Agency schedules Maraviroc in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25224. The term MARAVIROC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, No. 1, 2005, List 53). World Health Organization schedules maraviroc in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule maraviroc under HS 29333999 and SITC 51574. As of Q4 2014, MARAVIROC remains the US FDA Preferred Term for this commodity. Maraviroc bears US NLM identifiers UMLS ID C1667052 and NCI Concept Code C73144. SMILES: FC1(F)CCC(C(=O)NC(CCN2C3CC(n4c(nnc4C)C(C)C)CC2CC3)c2ccccc2)CC1.

